Condition: Covid19 · Sponsor: Sorrento Therapeutics, Inc.
This is a double-blind study designed to investigate the efficacy, safety and PK of a single dose of COVI-DROPS or matched placebo in outpatient adults who have tested positive for COVID-19 and are either asymptomatic or have mild symptoms.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Future Innovative Treatments, LLC | Colorado Springs, Colorado, United States | — |
| Clinical Neuroscience dba CNS Healthcare | Jacksonville, Florida, United States | — |
| Med-Care Research | Miami, Florida, United States | — |
| Clinical Neuroscience Solutions Healthcare | Orlando, Florida, United States | — |
| Precision Research Center | Tampa, Florida, United States | — |
| Clinical Site Partners, Inc | Winter Park, Florida, United States | — |
| Randomize Now | Peachtree City, Georgia, United States | — |
| Revival Research Institute | Dearborn, Michigan, United States | — |
| Quality Clinical Research | Omaha, Nebraska, United States | — |
| Remington Davis | Columbus, Ohio, United States | — |
| Cyn3rgy Research | Gresham, Oregon, United States | — |
| WR-ClinSearch | Chattanooga, Tennessee, United States | — |
+ 6 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04906694